Abstract How endoplasmic reticulum (ER) stress leads to cytotoxicity is ill-defined. Previously we showed that HeLa cells readjust homeostasis upon proteostatically driven ER stress, triggered by inducible bulk expression of secretory immunoglobulin M heavy chain (m s ) thanks to the unfolded protein response (UPR; Bakunts et al., 2017). Here we show that conditions that prevent that an excess of the ER resident chaperone (and UPR target gene) BiP over m s is restored lead to m s -driven proteotoxicity, i.e. abrogation of HRD1-mediated ER-associated degradation (ERAD), or of the UPR, in particular the ATF6a branch. Such conditions are tolerated instead upon removal of the BiP-sequestering first constant domain (C H 1) from m s . Thus, our data define proteostatic ER stress to be a specific consequence of inadequate BiP availability, which both the UPR and ERAD redeem.
Introduction
It is well-established that accumulation of unfolded proteins in the endoplasmic reticulum (ER)-a condition referred to as ER stress-activates the unfolded protein response (UPR), which, in turn, mitigates the stress, most notably through enhancing the ER chaperone content to boost the protein folding capacity (Walter and Ron, 2011) . What defines ER stress, and how ER stress may engender cytotoxicity, however, are poorly understood issues. Moreover, it is still debated what feature of ER stress activates the UPR. An important reason why these are still open questions is the wide-spread use of ER stress-eliciting drugs, such as tunicamycin (Tm), which inhibits N-glycosylation, or thapsigargin (Tg), which causes Ca 2+ efflux from the ER (Walter and Ron, 2011) . These drugs have pleiotropic effects and are inherently cytotoxic, hence obscuring important aspects of how ER homeostasis can be restored by virtue of the UPR or not. To overcome the shortcomings of ER stress-eliciting drugs, we recently have developed a HeLa cell-based model for proteostatically driven ER stress (Bakunts et al., 2017) . Inducible overexpression of the IgM subunits m s and the l light chain, in stoichiometric amounts, leads to bulk secretion of IgM with little if any UPR activation.
In the absence of l, however, m s is retained in the ER, and maximally activates the three main UPR branches, governed by IRE1a, PERK, and respectively, ATF6a. Yet, the cells successfully adapt to the proteostatic insult by expanding the ER both in size and in chaperone content, such that cell viability and growth are unaffected in the process, and UPR signaling subsides to a submaximal amplitude once homeostasis is restored (Bakunts et al., 2017) .
The ER resident chaperone BiP stands out in the course of the adaptation to m s expression in two ways. First, ER stress sensing and UPR signaling occur in a m s /BiP ratiometric fashion, that is the amplitude of UPR signaling is maximal when m s levels eclipse those of BiP, which is sequestered through binding to m s , while UPR signaling subsides to submaximal output when an excess of BiP over m s is restored (Bakunts et al., 2017) . ER homeostatic readjustment is due to the UPR, since BiP is a key UPR target gene (Walter and Ron, 2011) . Second, ER homeostatic readjustment to m s expression causes a~10-fold increase of BiP levels overall, which entails that BiP shifts from about one tenth to about one third of the total protein mass in the ER, such that BiP is the only chaperone in the ER of which the levels outmatch those of m s (Bakunts et al., 2017) .
The two main models that have been proposed for UPR activation are that it entails i) dissociation of BiP from the lumenal domains of the main ER stress sensors, IRE1a, PERK and ATF6a (Shen et al., 2002) , and ii) direct binding of unfolded proteins (Gardner and Walter, 2011; Karagö z et al., 2017) , including the Ig heavy chain C H 1 domain (Karagö z et al., 2017) , to these sensors. Based on insights obtained from m s -driven ER stress, we argue that these two UPR activation models are not mutually exclusive. Rather, the two models are complementary and should be unified, since in a three-way competition between UPR sensors, BiP, and an ER client protein (m s ) for binding one another, the ratio of UPR sensors bound to the client versus those bound to BiP most robustly report on the client/BiP ratio, to which indeed the UPR signaling amplitude correlates (Bakunts et al., 2017) .
HeLa cells tolerate genetic ablation of the main three UPR transducers, but expression of m s in the context of UPR-ablated cells causes synthetic lethality through apoptosis, underscoring the key role the UPR has in restoring ER homeostasis (Bakunts et al., 2017) . In this study we exploited this synthetic lethality to define how ER stress becomes proteotoxic.
Results
IRE1a and PERK are expendable, but ATF6a is key for m s -provoked ER homeostatic readjustment
To investigate in detail how the UPR sustains ER homeostatic readjustment to bulk m s expression, we exploited cells in which IRE1a was deleted and PERK and ATF6a were silenced with good efficiency (Bakunts et al., 2017) , either individually or in combinations. Surprisingly, ablation of IRE1a and PERK (either individually or in combination) had negligible effects on viability and growth of m sexpressing cells, ( Figure 1A,B) , or on ATF6a activation ( Figure 1C) . Thus, IRE1a and PERK are dispensable for restoring ER homeostasis upon bulk m s expression, and ER stress levels are not enhanced in their absence (although there is some ATF6a activation already under basal conditions when IRE1a and PERK are ablated; Figure 1C ). Conversely, silencing of ATF6a alone caused reduced growth and/or viability of m s -expressing cells ( Figure 1A,B) , implying that ER homeostasis was not (fully) restored.
When m s is expressed for 3 days in wild-type cells, ER homeostasis is restored, and, consequently, IRE1a and PERK signaling subsides to submaximal output (Bakunts et al., 2017) . In ATF6a-silenced cells, conversely, ER homeostasis is not restored, and, accordingly, signaling through the PERK and IRE1a pathways remained persistently high ( Figure 1C) ; that is levels of CHOP, a key downstream effector of PERK , were increased, and IRE1a-mediated XBP1 mRNA splicing (Calfon et al., 2002) was enhanced, as was evident from the increased prominence of the higher mobility band, corresponding to the RT-PCR product of the XBP1 S transcript from which the intron has been removed (Calfon et al., 2002) . Ablation of ATF6a in combination with ablation of IRE1a and/or PERK caused apoptosis (Bakunts et al., 2017) and, consequently, abrogated viability of m sexpressing cells ( Figure 1A ,B). We concluded that accumulation of m s in the ER per se confers proteotoxicity when the UPR is dysfunctional, and that the UPR counteracts this proteotoxicity, in particular through the ATF6a branch.
IRE1a and PERK are expendable, but ATF6a is key for ER expansion in response to m s expression ER stress and ensuing cytotoxicity levels correlate with the extent of m s being chaperoned
Since the UPR induces expression of ER resident chaperones, we surmised that m s -driven ER stress becomes cytotoxic when the UPR is compromised, in particular upon ATF6a ablation, due to 'underchaperoning' of m s . Proteins that undergo folding tend to aggregate in absence of sufficient folding assistance. Upon ablation of IRE1a and ATF6a, m s indeed formed extensively disulfide-linked high molecular weight species that partitioned into a NP40-insoluble fraction, indicative of aggregation (Mattioli et al., 2006; Valetti et al., 1991) -with the single ablations showing intermediate phenotypes-( Figure 3A) . Under basal conditions, a significant proportion of BiP readily converts into an inactive, AMPylated state upon a three-hour block of protein synthesis with cycloheximide (CHX) ( Figure 3B ), which indicates that BiP gets to be dismissed from its chaperoning duties once its regular clients have had sufficient time to complete their folding, as has been reported before (Preissler et al., 2015) . Conversely, in m s -expressing cells no AMPylation occurred upon CHX treatment at any time upon the onset of m s expression ( Figure 3B) , suggesting that the vast majority of BiP is permanently engaged in chaperoning m s even though the BiP pool is expanding massively in response to m s expression (Bakunts et al., 2017) .
As BiP stands out as a key chaperone for orphan m s , we reasoned that the level of BiP at basal conditions is a key determinant for m s -driven ER stress susceptibility. To test this idea, we created a derivative of the HeLa-m s cell line with an integrated copy of the hamster HSPA5 gene that encodes BiP under control of doxycycline (Dox). The induction of m s with Mif leads to it being the most abundantly transcribed gene (Bakunts et al., 2017) in the cells and concomitant induction of other transgenes would lead to competition for the transcription and/or translation machineries (not shown), thereby mitigating m s expression and, hence, m s -driven ER stress by default. We therefore decided to pre-emptively enhance BiP levels with Dox at least~10 fold prior to induction of m s expression ( Figure 3C ). Even though exogenously driven BiP transcription ceased after that, exogenous (hamster) BiP levels remained high for a prolonged time ( Figure 3C ). Figure 2 . ATF6a is essential but IRE1a and PERK are dispensable for upregulation of ER chaperones and ER expansion in response to m s expression. (A,B) HeLa-m s cells in which UPR transducers were ablated by silencing alone or in combination, or not (WT), as indicated, were induced with 0.5 nM Mif to express m s for 3 days or not. The cells harbor APEX-KDEL, a modified version of pea peroxidase that is targeted to the ER, and that catalyzes polymerization of 3,3'-diaminobenzidine tetrahydrochloride (DAB) upon treatment with H 2 O 2 to obtain DAB precipitates (dark), revealing the extent of the ER in electron micrographs. Boxed areas are shown by 3-fold magnification; scale bars represent 1 mm (A). The extent of ER expansion was assessed as described (Bakunts et al., 2017) , and the percentage of the area within the cytoplasm corresponding to ER was determined and depicted in bar graphs (B). Mean and s.e.m. are shown, n = 10-20. (C-E) Cells were induced to express m s for the indicated times. Levels of m s (D) and BiP (E) were quantitated from (C), and replicate experiments. (D) Levels in WT of m s at 64 hr were set at 100 that was scaled to levels of BiP in WT at 64 hr such as to reflect a ratio of m s to BiP of 2:3, that is an estimate for this ratio at day three based on earlier quantitations that we have described (Bakunts et al., 2017 ). Mean and s.e.m. are shown in bar graphs; n = 2-5. Statistical significance in the extent of ER areas in the electron micrographs between m s -expressing or non-expressing cells (black), or between m s -expressing WT or ATF6a ablated cells (red) (B), or in expression levels (D,E) was tested by ANOVA (n.s., not significant; *p0.05; **p0.01; ***p0.001). DOI: https://doi.org/10.7554/eLife.41168.004
The following source data and figure supplement are available for figure 2:
Source data 1. In line with the notion that ER stress sensing in the HeLa-m s model occurs in a m s /BiP ratiometric fashion (Bakunts et al., 2017) , and in line with earlier reports that BiP overexpression dampens UPR activation , XBP1 mRNA splicing and upregulation of the UPR target GRP94 occurred with a delay when BiP levels were exogenously boosted as compared to when BiP was at endogenous levels, in spite of the similar extent and kinetics of m s accumulation ( Figure 3C ). Altogether the HeLa-m s model thus provides further support that sensing of ER stress correlates with the extent of the folding machinery being engaged in chaperoning its clients, and that BiP sequestration by client proteins appears to serve as the main proxy for that.
Turnover of m s as afforded by ERAD is remarkably robust
While m s levels increase, and the ER expands (~3-4 fold compared to basal levels), as wild-type cells are still adapting to the proteostatic insult, there is no further build-up of m s levels and ER expansion after~2-3 days once homeostasis is restored (Bakunts et al., 2017) , which implies that at that stage the influx of m s molecules into the ER must be matched by countermeasures. Translational attenuation through PERK activation can alleviate the burden on the ER folding machinery by diminishing the input of nascent clients entering the ER lumen (Harding et al., 1999 ). Yet, we ruled out that PERK-driven translational attenuation was a key determinant for ER homeostatic readjustment in the HeLa-m s model, considering that PERK ablation hardly impeded cell growth upon m s expression ( Figure 1A,B) . Accordingly, there was only a marginal reduction in overall protein synthesis (being at the lowest~80% of that before induction) that was moreover transient Immunoblotting of lysates revealed levels of m s , total BiP, hamster BiP, and GRP94. XBP1 mRNA splicing was assessed as in Figure 1C . DOI: https://doi.org/10.7554/eLife.41168.007 also ruled out that regulated IRE1a-dependent decay (RIDD) (Hollien and Weissman, 2006; Hollien et al., 2009 ) of mRNAs that encode ER client proteins (and thereby limiting their influx into the ER) is important for homeostatic readjustment upon m s expression, since ablation of IRE1a had negligible impact on cell growth ( Figure 1A,B) . However, m s is a target of ERAD, as has been shown in plasma cells (Fagioli and Sitia, 2001) , and which is shown here for the HeLa-m s cell model, since the proteasomal inhibitor MG132 to a large extent stabilizes m s levels in pulse-chase assays ( Figure 4A ,B). Since m s is glycosylated, it is subject to mannose trimming (Aebi et al., 2010) , which is a key step in delivering m s to the retro-translocation machinery that shuttles it to the cytosol for proteasomal degradation (Fagioli and Sitia, 2001) . Accordingly, the ER mannosidase I inhibitor kifunensine (Kif) stabilized m s in a similar manner as MG132 ( Figure 4A,B) . Interestingly, while m s levels built up steadily in the ER with time, ERAD kinetics hardly changed (i.e. the half-life (t ½ ) of m s was remarkably constant), which implies that ERAD prowess kept pace with the accumulating load of m s ( Figure 4C ). ERAD components are UPR target genes (Walter and Ron, 2011) , and indeed various major ERAD components (HRD1, SEL1L, Ube2j1, HERP, and OS-9), which we previously failed to detect by proteomics (Bakunts et al., 2017) , were upregulated upon m s expression (Figure 4-figure supplement 2 ), Yet, their upregulation apparently serves at most to maintain rather than to reinvigorate ERAD kinetics of the accumulating m s load. In fact, ERAD kinetics of m s were not markedly affected by ablation of ATF6a ( Figure 4D ,E), in line with the finding that intracellular m s accumulation was not aggravated upon ATF6a ablation ( Figure 2C,D) . Thus, ER homeostatic failure upon ATF6a ablation is not due to compromised ERAD. Apparently, the upkeep of ERAD is robust in HeLa-m s cells, since we can also rule out that IRE1a and/or PERK are essential for maintaining sufficient ERAD capacity, as their ablation hardly caused any growth impairment of m s -expressing cells ( Figure 1A,B) , unlike when ERAD is inhibited-see below. 
Disposal of m s through HRD1 complex-mediated ERAD is key for homeostatic readjustment
While prolonged proteasomal inhibition in itself is cytotoxic, blocking ERAD of glycoproteins with Kif per se did not affect cell viability ( Figure 5A ), and did not activate the UPR either ( Figure 5 -figure supplement 1). We reasoned that ERAD would be important, however, to hold bulk accumulation of m s in check. Indeed, viability was compromised in Kif-treated m s -expressing cells ( Figure 5A ). Key ERAD components are the E3 ligase HRD1 and its partner SEL1L (Olzmann et al., 2013) , which have previously been shown to mediate ERAD of m s (Cattaneo et al., 2008) . Indeed, ablation of HRD1 and, to a lesser extent, of SEL1L was synthetically lethal in HeLa-m s cells upon m s expression ( Figure 5A ). HRD1 and SEL1L cooperate to target ERAD substrates back across the ER membrane to the cytosol, where substrates are ubiquitinated, deglycosylated by N-glycanase, and, ultimately, degraded by the proteasome (Olzmann et al., 2013) . Accordingly, m s was stabilized in HRD1 KO or SEL1L KD cells, similarly as upon Kif treatment of WT cells, while in ERAD-competent WT cells m s was degraded upon CHX treatment ( Figure 5B,C) . Proteasomal inhibition with MG132 stabilized m s in WT cells, and the appearance of a deglycosylated form of m s confirmed that, at least of fraction of m s was retrotranslocated to the cytosol, and accessible to N-glycanase. Interestingly, in HRD1 KO or SEL1L KD cells no deglycosylated form of m s appeared, indicating that disposal of m s was blocked at (or prior to) the retrotranslocation step ( Figure 5C ).
There appear to be more than 25 other E3 ligases that localize at the ER membrane next to HRD1 (Neutzner et al., 2011; Kaneko et al., 2016) , but, curiously, none of these can compensate for the loss of HRD1. Furthermore, treatment with the autophagy inhibitor Bafilomycin A1 (BafA1) did not lead to any stabilization of m s ( Figure 5B ). Thus, HRD1-mediated ERAD is the main if not exclusive disposal mechanism that is essential for ER homeostatic readjustment in the HeLa-m s model, even though autophagy has been reported to curtail IgM production and ER expansion in plasma cells (Pengo et al., 2013) .
The synthetic lethality that ensues once ERAD is compromised in the HeLa-m s model offered a powerful tool to define which factors are crucial to act in conjunction with HRD1 and SEL1L in the disposal of m s . To that end, we ablated several candidate HRD1 partners by CRISPR/Cas9 (but without clonal selection; that is without necessarily reaching fully penetrant phenotypes). In this initial survey, we witnessed that cell viability upon m s -expression was compromised, and that m s was stabilized in a CHX chase by ablation of HERP, Ube2j1, and Derlin2 to significant extents ( Figure 5-figure supplement 2) . However, ablation of OS-9 or of XTP3-B only mildly affected m s -expressing cells. These two lectins indeed have been shown previously to be interchangeable, as they capture soluble ERAD substrates upon mannose trimming of their glycans before handing over these substrates to SEL1L van der Goot et al., 2018) .
In sedimentation gradients HRD1, SEL1L, and Derlin2 shifted towards heavier fractions upon m s expression, while the redundant ERAD factor OS-9 did not ( Figure 5D ). These findings indicate that disposal of m s is effectuated through assembly of higher-order ERAD-mediating complexes with, at the least, HRD1, SEL1L, and Derlin2 at their core. These complexes nucleate around HRD1 as its ablation abrogated their formation ( Figure 5D ).
Homeostatic failure upon ERAD inhibition coincides with m s levels outpacing BiP upregulation
When ERAD is functional, an excess of BiP over m s is restored upon 3 days of m s expression. The BiP:m s stoichiometry is then~3:2, as estimated from a combination of quantitative immunoblotting and proteomics techniques (Bakunts et al., 2017) . As soon as BiP levels are in excess again, UPR signaling subsides to submaximal output, and ER homeostatic readjustment to m s expression is successful (Bakunts et al., 2017) . The loss of viability in Kif-treated m s -expressing cells ( Figure 5A ) indicated that ER homeostatic readjustment failed, and these cells indeed underwent apoptosis ( Figure 6A ). Homeostatic failure in Kif-treated m s -expressing cells entailed that ER stress was unresolved, and accordingly, IRE1a and PERK chronically signaled at maximal levels ( Figure 6B) .
Chronic maximal UPR activation upon ERAD inhibition in m s -expressing cells implied that induction of BiP expression was persistently at maximal levels. Nevertheless, the build-up of BiP levels (~2 fold further increase after 3 days), could not keep pace with the augmented accumulation of m s (~3 (Bakunts et al., 2017) . (B) Levels of BiP and m s were assessed by quantitative immunoblotting as described (Bakunts et al., 2017) , and depicted in bar graphs as in Figure 2D ,E, such that the m s levels in the absence of Kif were scaled to BiP levels at a ratio of 2:3. Levels in the presence of Kif are expressed as a fold change compared to levels in the absence of Kif; mean and s.e.m. are shown; n = 2. (D) In cells harboring APEX-KDEL the extent of ER expansion was assessed as in Figure 2A . Boxed areas are shown by 3-fold magnification; scale bars represent 1 mm. The percentage of the dark area within the cytoplasm corresponding to ER was determined and depicted in bar graphs (E), mean and s.e.m. are shown, n = 10. Statistical significance of differences in Annexin V staining (A), or the extent of ER occupying cytosolic area in the electron micrographs (E) were tested by ANOVA (*p0.05; ***p0.001). DOI: https://doi.org/10.7554/eLife.41168.016
The following source data is available for figure 6:
Source data 1. DOI: https://doi.org/10.7554/eLife.41168.017
fold further increase after 3 days) upon ERAD inhibition, such that m s reached levels in the ER that were at about a 1:1 stoichiometry with BiP ( Figure 6C) . Indeed, aggregation of m s increased when ERAD was defective, as judged by m s shifting more towards heavier fractions in HRD1 KO than in WT cells ( Figure 5D ). Thus, under those conditions the chaperoning machinery becomes limiting, similarly as upon ablation of IRE1a and/or ATF6a in ERAD-competent cells ( Figure 3A) . We previously estimated the volume of the ER under basal conditions to be (0.10-0.12) 3/2 » 3-4% of the cytoplasmic volume, and upon 3 days of m s expression to be (0.18-0.20) 3/2 » 7-8% of the cytoplasmic volume, corresponding to a~2-3 fold increase of ER volume (Bakunts et al., 2017) . Upon ERAD inhibition with Kif the ER did not markedly expand in non-m s -expressing cells. In m s -expressing cells, instead, ERAD inhibition caused the area of ER staining within the cytoplasm to reach 30-35%, which on a rough estimate would account for (0.3-0.35) 3/2 » 17-20% of the cytoplasmic volume, implying that the ER had expanded~6-7 fold since the onset of m s -expression ( Figure 6D,E) .
We concluded that curtailing the m s load by ERAD is essential for the cells to cope with m s expression in bulk. ER homeostatic failure upon ERAD inhibition coincided with an inadequacy to raise BiP levels in sufficient excess over those of m s and, hence, with its 'under-chaperoning', in spite of the impressive BiP upregulation and ER expansion at large. Thus, in absence of ERAD, not only the chronic maximal UPR activation, but also the m s -driven proteotoxicity appear to be due to BiP running short, similarly as when UPR signaling was compromised upon ablation of ATF6a (Figure 1C,D ; Figure 2C -E).
Sequestration of BiP is both necessary and sufficient for UPR activation and ER stress-provoked proteotoxicity
In plasma cells BiP stringently interacts with m s through the C H 1 domain, until it is displaced by the light chain (Bole et al., 1986;  Figure 7A ), which makes m s an unusual ER client. Evolutionary pressure against secretion of orphan m s (i.e. unaccompanied by the light chain) must have been extraordinarily high for obvious immunological reasons (Anelli and van Anken, 2013) , which would explain the exceptionally strong affinity of the C H 1 domain for BiP, that is to let BiP mediate stringent ER retention of unpaired m s . Thus, we reasoned that removal of the BiP binding C H 1 domain from m s ( Figure 7A ), would offer an ideal tool to validate whether limitations in BiP availability define both the amplitude of UPR activation as well as any proteotoxicity that would ensue from overexpression of ER client proteins. In line with our model, m s DC H 1 hardly activated the UPR, as shown for the IRE1a and PERK branches, despite being expressed at similar levels as m s wild-type ( Figure 7B) . Moreover, genetic ablation of the three UPR pathways failed to cause synthetic lethality in m s DC H 1-expressing cells ( Figure 7C) . Conversely, co-expression of m s DC H 1 with a chimeric protein consisting of the variable domain of l fused with the C H 1 domain of m s (V L -C H 1), which teams up with m s DC H 1 through interactions between V L with the variable domain of m s (V H ) ( Figure 7A ), restored UPR activation ( Figure 7B ) and synthetic lethality upon UPR ablation ( Figure 7C ). These findings corroborate that the BiP sequestering C H 1 domain of m s causes UPR activation, as well as proteotoxicity when reinforcement of BiP levels through the UPR is inadequate.
Discussion
The fact that BiP plays a key role in regulating the UPR has been known for almost 20 years . Overexpression of BiP dampens UPR activation , which we confirm with the data presented here, while inactivating BiP with the AB5 subtilase cytotoxin acutely causes ER stress and UPR activation (Paton et al., 2006) . Yet, by employment of a proteostatic stimulus with a single well-defined BiP binding module as the source of ER stress, we have provided here experimental evidence that defines both proteostatic ER stress, and the resulting activation of the UPR, to be the specific consequence of insufficient BiP availability. Both the UPR and ERAD redress the relative BiP shortage, and thus counteract that the proteostatic stress becomes proteotoxic. BiP indeed has been acclaimed as the master regulator of ER function (Hendershot, 2004) , and various cytotoxic consequences may follow from the excessive sequestering of BiP by m s that precludes BiP from attending to its other functions. For instance, BiP closes off the translocon, and efflux of Ca 2+ from the ER into the cytosol through poorly gated translocons may already be sufficient to cause apoptosis (Schäuble et al., 2012) .
Our data emphasize that proteotoxicity stemming from the accumulation of client proteins in the ER is not the result of UPR signaling, as often is assumed from the notion that the UPR can initiate pro-apoptotic pathways. Instead, the UPR foremost counteracts proteotoxicity by inducing the ER resident folding machinery (most in particular BiP). In light of our data, the capacity of the UPR to switch from cytoprotective to pro-apoptotic signaling may well have arisen in metazoans to preemptively eliminate cells in which restoration of ER homeostasis is unachievable, and, hence, cell death has become inevitable.
Perhaps surprisingly, our results furthermore highlight that PERK and IRE1a are dispensable for successful ER homeostatic readjustment to the m s stimulus in HeLa cells. Apparently, the PERK-mediated translational block, which is only transient, offers negligible advantage when cells face a sudden proteostatic insult that sequesters BiP (and/or the ER chaperone machinery at large) in a persistent manner. PERK-mediated translational attenuation instead may be required in particular to sustain episodic secretory activity, such as in b-cells of the pancreas. PERK KO mice indeed suffer mostly from degeneration of tissues with episodic secretory activity (Zhang et al., 2002) . Similarly, requirements for the IRE1a/XBP1 pathway seem to be tissue-specific. Both deletion of IRE1a (Urano et al., 2000; Zhang et al., 2005) and of XBP1 (Reimold et al., 2000) cause embryonic lethality, but XBP1 KO mice are rescued with an XBP1 transgene specifically expressed in the liver (Lee et al., 2005) , while IRE1a KO mice are rescued when the placenta expresses IRE1a (Iwawaki et al., 2009) , and the resulting rescued mice display relatively mild symptoms, that ishyperglycemia, hypoinsulinemia, and decreased antibody titers, despite the lack of IRE1a (Iwawaki et al., 2010) . In line with our findings, homeostatic readjustment to ER stress in most mammalian tissues seems to rely mainly on ATF6 proteins (Wu et al., 2007; Yamamoto et al., 2007) , that is ATF6a, and its related ER stress sensor ATF6b. The ATF6a/b double KO confers embryonic lethality (Yamamoto et al., 2007) . At present, it is unclear whether embryonic lethality of the ATF6a/b double KO can be rescued, for instance through enhancement of other UPR branches.
Finally, since proteotoxicity due to the accumulation of (mutant) proteins in the ER seems to play a key role in various types of disease (Anelli and Sitia, 2010; Cao and Kaufman, 2014) , our insights may be of relevance for the design of drugs aimed at alleviating ER stress (Hetz and Papa, 2018) , and hence proteotoxicity stemming from ER stress. We argue that pharmacological intervention against pathogenic ER stress foremost should promote a favorable ratio of BiP levels over those of its disease-causing client protein.
Materials and methods
All assays were performed as described (Bakunts et al., 2017) , except that in addition, along the same principles as described (Bakunts et al., 2017) were tested in phenotypic assays to rule out off-target effects. CRISPR/Cas9-mediated depletion of HERP, Ube2j1, Derlin-2, OS-9, or XTP3-B in HeLa-m s was performed using single guide RNA (sgRNA) sequences (Supplementary file 1) cloned into the PX459 vector (Addgene #62988) and were used as puromycin-selected pools without clonal isolation. Cloning into PX459 was performed as described previously (Ran et al., 2013) . sgRNA target sequences for Hrd1, HERP (Schulz et al., 2017) , Derlin-2, Ube2j1 (Ma et al., 2015) , OS-9, and XTP3-B (van der Goot et al., 2018) have been described previously. Silencing of SEL1L was obtained using ON-Target SMARTpool siRNA from Dharmacon. The inducible hamster BiP, m s DC H 1 and V L -C H 1 cassettes were created by standard molecular biology techniques from the cDNAs described in Bakunts et al. (2017) . The C H 1 domain (E140-P244) was deleted from m s in m s DC H 1. That same C H 1 domain was placed downstream of V127 of l, replacing the C L domain, to create the chimeric V L -C H 1 construct. A myc tag (EQKLISEEDL) was placed at the C-terminus of V L -C H 1 for immunodetection purposes. Cells were routinely tested, that is on a monthly basis, to be mycoplasm-free by use of a standard diagnostic PCR. All cell lines in this study were ultimately derived from HeLa S3 cells, of which the genotype was confirmed by PCR single locus technology. Antibodies used in addition to those described before (Bakunts et al., 2017) are summarized in Supplementary file 1.
To separate NP-40 soluble from insoluble fractions, cells were washed and lysed in 0.2% NP-40, 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM EDTA, 10 mM N-ethylmaleimide and a cocktail of protease inhibitors. The NP-40-insoluble fractions were separated from the soluble fractions by centrifugation at 3,400 g for 10 min and the insoluble pellets were solubilized in 1% SDS, 50 mM Tris-HCl pH 7.5, 10 mM NEM for 10 min at RT and sonicated on ice. For fractionation of ERAD complexes cells were lysed in 1% lauryl maltose neopentyl glycol (LMNG, Anatrace) containing buffer (50 mM Tris-HCl, pH7.4, 150 mM NaCl, 5 mM EDTA) and lysates were loaded onto 10-40% sucrose gradients also containing 1% LMNG, formed by following the manufacturers' instructions (Gradient Master, Biocomp). Sedimentation was achieved by centrifugation in a SW.41 swing bucket rotor (Beckman) at 39,000 rpm for 16 hr at 4˚C. Thirteen fractions were collected from the top and proteins precipitated with TCA (trichloroacetic acid). Protein pellets were resuspended in Laemmli buffer containing DTT (10 mM), heated alongside 25 mg of the original lysates as input, at 56˚C prior to separation by SDS-PAGE.
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